-
1
-
-
76349106646
-
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes
-
Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170-8.
-
(2010)
J Natl Cancer Inst
, vol.102
, Issue.3
, pp. 170-178
-
-
Virnig, B.A.1
Tuttle, T.M.2
Shamliyan, T.3
Kane, R.L.4
-
2
-
-
84938908533
-
-
Cancer Facts & Figures 2014
-
Society AC. Cancer Facts & Figures 2014. American Cancer Society. Cancer.org. 2014;8-10.
-
(2014)
American Cancer Society. Cancer.org
, pp. 8-10
-
-
-
3
-
-
20444379234
-
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
-
Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103(12):2481-4.
-
(2005)
Cancer
, vol.103
, Issue.12
, pp. 2481-2484
-
-
Sanders, M.E.1
Schuyler, P.A.2
Dupont, W.D.3
Page, D.L.4
-
4
-
-
0029121769
-
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
-
Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197-200.
-
(1995)
Cancer
, vol.76
, Issue.7
, pp. 1197-1200
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Jensen, R.A.4
Schuyler, P.A.5
-
5
-
-
84938919101
-
Stage 0 Breast Cancer
-
Network NCC. Stage 0 Breast Cancer. NCCN Guidlines for Patients. 2014;1(2014):17-28.
-
(2014)
NCCN Guidlines for Patients
, vol.1
, Issue.2014
, pp. 17-28
-
-
-
6
-
-
0036990109
-
The organizing principle: microenvironmental influences in the normal and malignant breast
-
Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation. 2002;70(9-10):537-46.
-
(2002)
Differentiation
, vol.70
, Issue.9-10
, pp. 537-546
-
-
Bissell, M.J.1
Radisky, D.C.2
Rizki, A.3
Weaver, V.M.4
Petersen, O.W.5
-
7
-
-
34247864012
-
Three-dimensional culture models of normal and malignant breast epithelial cells
-
Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4(4):359-65.
-
(2007)
Nat Methods
, vol.4
, Issue.4
, pp. 359-365
-
-
Lee, G.Y.1
Kenny, P.A.2
Lee, E.H.3
Bissell, M.J.4
-
8
-
-
67549125238
-
Gene expression profiling of the tumor microenvironment during breast cancer progression
-
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11(1):R7.
-
(2009)
Breast Cancer Res
, vol.11
, Issue.1
, pp. R7
-
-
Ma, X.J.1
Dahiya, S.2
Richardson, E.3
Erlander, M.4
Sgroi, D.C.5
-
9
-
-
23044499067
-
Distinct epigenetic changes in the stromal cells of breast cancers
-
Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005;37(8):899-905.
-
(2005)
Nat Genet.
, vol.37
, Issue.8
, pp. 899-905
-
-
Hu, M.1
Yao, J.2
Cai, L.3
Bachman, K.E.4
van den Brule, F.5
Velculescu, V.6
-
10
-
-
79953731991
-
Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects
-
Sung KE, Yang N, Pehlke C, Keely PJ, Eliceiri KW, Friedl A, et al. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol. 2011;3(4):439-50.
-
(2011)
Integr Biol
, vol.3
, Issue.4
, pp. 439-450
-
-
Sung, K.E.1
Yang, N.2
Pehlke, C.3
Keely, P.J.4
Eliceiri, K.W.5
Friedl, A.6
-
11
-
-
84881030156
-
Cancer associated fibroblasts'--more than meets the eye
-
Madar S, Goldstein I, Rotter V. Cancer associated fibroblasts'--more than meets the eye. Trends Mol Med. 2013;19(8):447-53.
-
(2013)
Trends Mol Med
, vol.19
, Issue.8
, pp. 447-453
-
-
Madar, S.1
Goldstein, I.2
Rotter, V.3
-
12
-
-
70149088171
-
Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution
-
Campbell I, Polyak K, Haviv I. Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. Cancer Res. 2009;69(17):6765-8. discussion 6769.
-
(2009)
Cancer Res
, vol.69
, Issue.17
, pp. 6765-6768
-
-
Campbell, I.1
Polyak, K.2
Haviv, I.3
-
13
-
-
42549152045
-
No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas
-
Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet. 2008;40(5):650-5.
-
(2008)
Nat Genet
, vol.40
, Issue.5
, pp. 650-655
-
-
Qiu, W.1
Hu, M.2
Sridhar, A.3
Opeskin, K.4
Fox, S.5
Shipitsin, M.6
-
14
-
-
84901020848
-
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment
-
Augsten M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;4:62.
-
(2014)
Front Oncol.
, vol.4
, pp. 62
-
-
Augsten, M.1
-
15
-
-
0025794282
-
Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis
-
Tamm I, Cardinale I, Murphy JS. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci U S A. 1991;88(10):4414-8.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, Issue.10
, pp. 4414-4418
-
-
Tamm, I.1
Cardinale, I.2
Murphy, J.S.3
-
16
-
-
0028345171
-
E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells
-
Tamm I, Cardinale I, Kikuchi T, Krueger JG. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci U S A. 1994;91(10):4338-42.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.10
, pp. 4338-4342
-
-
Tamm, I.1
Cardinale, I.2
Kikuchi, T.3
Krueger, J.G.4
-
17
-
-
0025863361
-
Expression and function of interleukin-6 in epithelial cells
-
Krueger J, Ray A, Tamm I, Sehgal PB. Expression and function of interleukin-6 in epithelial cells. J Cell Biochem. 1991;45(4):327-34.
-
(1991)
J Cell Biochem
, vol.45
, Issue.4
, pp. 327-334
-
-
Krueger, J.1
Ray, A.2
Tamm, I.3
Sehgal, P.B.4
-
18
-
-
47249161129
-
Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function
-
Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, et al. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem. 2008;283(21):14665-73.
-
(2008)
J Biol Chem
, vol.283
, Issue.21
, pp. 14665-14673
-
-
Cheng, G.Z.1
Zhang, W.Z.2
Sun, M.3
Wang, Q.4
Coppola, D.5
Mansour, M.6
-
19
-
-
69249221254
-
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
-
Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009;28(33):2940-7.
-
(2009)
Oncogene
, vol.28
, Issue.33
, pp. 2940-2947
-
-
Sullivan, N.J.1
Sasser, A.K.2
Axel, A.E.3
Vesuna, F.4
Raman, V.5
Ramirez, N.6
-
20
-
-
0028226196
-
Soluble receptors for cytokines and growth factors: generation and biological function
-
Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994;300(Pt 2):281-90.
-
(1994)
Biochem J
, vol.300
, pp. 281-290
-
-
Rose-John, S.1
Heinrich, P.C.2
-
21
-
-
76249110097
-
Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes
-
Mohamed MM, Cavallo-Medved D, Rudy D, Anbalagan A, Moin K, Sloane BF. Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes. Cell Physiol Biochem. 2010;25(2-3):315-24.
-
(2010)
Cell Physiol Biochem
, vol.25
, Issue.2-3
, pp. 315-324
-
-
Mohamed, M.M.1
Cavallo-Medved, D.2
Rudy, D.3
Anbalagan, A.4
Moin, K.5
Sloane, B.F.6
-
22
-
-
85019193905
-
Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression
-
Bengsch F, Buck A, Gunther SC, Seiz JR, Tacke M, Pfeifer D, et al. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. 2013.
-
(2013)
Oncogene
-
-
Bengsch, F.1
Buck, A.2
Gunther, S.C.3
Seiz, J.R.4
Tacke, M.5
Pfeifer, D.6
-
23
-
-
0033921535
-
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue
-
Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch Jr G, Klocker H, et al. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol. 2000;191(3):239-44.
-
(2000)
J Pathol
, vol.191
, Issue.3
, pp. 239-244
-
-
Hobisch, A.1
Rogatsch, H.2
Hittmair, A.3
Fuchs, D.4
Bartsch Jr, G.5
Klocker, H.6
-
24
-
-
0033564755
-
Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma
-
Kinoshita T, Ito H, Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer. 1999;85(12):2526-31.
-
(1999)
Cancer
, vol.85
, Issue.12
, pp. 2526-2531
-
-
Kinoshita, T.1
Ito, H.2
Miki, C.3
-
25
-
-
84865422083
-
Interleukin-6 signaling pathway in targeted therapy for cancer
-
Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38(7):904-10.
-
(2012)
Cancer Treat Rev
, vol.38
, Issue.7
, pp. 904-910
-
-
Guo, Y.1
Xu, F.2
Lu, T.3
Duan, Z.4
Zhang, Z.5
-
26
-
-
84878552107
-
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8
-
Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, et al. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 2013;73(11):3470-80.
-
(2013)
Cancer Res.
, vol.73
, Issue.11
, pp. 3470-3480
-
-
Hartman, Z.C.1
Poage, G.M.2
den Hollander, P.3
Tsimelzon, A.4
Hill, J.5
Panupinthu, N.6
-
27
-
-
80051616701
-
Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells
-
Jiang XP, Yang DC, Elliott RL, Head JF. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells. Anticancer Res. 2011;31(9):2899-906.
-
(2011)
Anticancer Res
, vol.31
, Issue.9
, pp. 2899-2906
-
-
Jiang, X.P.1
Yang, D.C.2
Elliott, R.L.3
Head, J.F.4
-
28
-
-
77957365010
-
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation
-
Leslie K, Gao SP, Berishaj M, Podsypanina K, Ho H, Ivashkiv L, et al. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Res. 2010;12(5):R80.
-
(2010)
Breast Cancer Res
, vol.12
, Issue.5
, pp. R80
-
-
Leslie, K.1
Gao, S.P.2
Berishaj, M.3
Podsypanina, K.4
Ho, H.5
Ivashkiv, L.6
-
29
-
-
84931332357
-
Evaluation of chemotherapeutics in a three-dimensional breast cancer model
-
Lovitt CJ, Shelper TB, Avery VM. Evaluation of chemotherapeutics in a three-dimensional breast cancer model. J Cancer Res Clin Oncol. 2015;141(5):951-9.
-
(2015)
J Cancer Res Clin Oncol
, vol.141
, Issue.5
, pp. 951-959
-
-
Lovitt, C.J.1
Shelper, T.B.2
Avery, V.M.3
-
30
-
-
0030044330
-
MCF10AT: a model for the evolution of cancer from proliferative breast disease
-
Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol. 1996;148(1):313-9.
-
(1996)
Am J Pathol
, vol.148
, Issue.1
, pp. 313-319
-
-
Dawson, P.J.1
Wolman, S.R.2
Tait, L.3
Heppner, G.H.4
Miller, F.R.5
-
31
-
-
71549136169
-
Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ
-
Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Res. 2009;69(23):9148-55.
-
(2009)
Cancer Res
, vol.69
, Issue.23
, pp. 9148-9155
-
-
Jedeszko, C.1
Victor, B.C.2
Podgorski, I.3
Sloane, B.F.4
-
32
-
-
84857824501
-
MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression
-
Sameni M, Anbalagan A, Olive MB, Moin K, Mattingly RR, Sloane BF. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression. J Vis Exp. 2012;(60). doi: 10.3791/3661.
-
(2012)
J Vis Exp
, Issue.60
-
-
Sameni, M.1
Anbalagan, A.2
Olive, M.B.3
Moin, K.4
Mattingly, R.R.5
Sloane, B.F.6
-
33
-
-
63049095880
-
Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation
-
Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res. 2009;315(7):1234-46.
-
(2009)
Exp Cell Res
, vol.315
, Issue.7
, pp. 1234-1246
-
-
Cavallo-Medved, D.1
Rudy, D.2
Blum, G.3
Bogyo, M.4
Caglic, D.5
Sloane, B.F.6
-
34
-
-
0028273525
-
Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene
-
Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci. 1994;107(Pt 2):373-84.
-
(1994)
J Cell Sci
, vol.107
, pp. 373-384
-
-
Sloane, B.F.1
Moin, K.2
Sameni, M.3
Tait, L.R.4
Rozhin, J.5
Ziegler, G.6
-
35
-
-
84869389974
-
Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins
-
Mullins SR, Sameni M, Blum G, Bogyo M, Sloane BF, Moin K. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins. Biol Chem. 2012;393(12):1405-16.
-
(2012)
Biol Chem
, vol.393
, Issue.12
, pp. 1405-1416
-
-
Mullins, S.R.1
Sameni, M.2
Blum, G.3
Bogyo, M.4
Sloane, B.F.5
Moin, K.6
-
36
-
-
84877826703
-
The role of intratumoral and systemic IL-6 in breast cancer
-
Dethlefsen C, Hojfeldt G, Hojman P. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 2013;138(3):657-64.
-
(2013)
Breast Cancer Res Treat
, vol.138
, Issue.3
, pp. 657-664
-
-
Dethlefsen, C.1
Hojfeldt, G.2
Hojman, P.3
-
37
-
-
0037591513
-
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
-
Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer. 2003;88(11):1721-6.
-
(2003)
Br J Cancer
, vol.88
, Issue.11
, pp. 1721-1726
-
-
Bachelot, T.1
Ray-Coquard, I.2
Menetrier-Caux, C.3
Rastkha, M.4
Duc, A.5
Blay, J.Y.6
-
38
-
-
0037455841
-
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
-
Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, et al. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer. 2003;103(5):642-6.
-
(2003)
Int J Cancer
, vol.103
, Issue.5
, pp. 642-646
-
-
Salgado, R.1
Junius, S.2
Benoy, I.3
Van Dam, P.4
Vermeulen, P.5
Van Marck, E.6
-
39
-
-
84918521700
-
An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells
-
Yang L, Han S, Sun Y. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells. Biochem Biophys Res Commun. 2014;453(3):582-7.
-
(2014)
Biochem Biophys Res Commun
, vol.453
, Issue.3
, pp. 582-587
-
-
Yang, L.1
Han, S.2
Sun, Y.3
-
40
-
-
84908318907
-
Up-regulated cten by FGF2 contributes to FGF2-mediated cell migration
-
Hung SY, Shih YP, Chen M, Lo SH. Up-regulated cten by FGF2 contributes to FGF2-mediated cell migration. Mol Carcinog. 2014;53(10):787-92.
-
(2014)
Mol Carcinog
, vol.53
, Issue.10
, pp. 787-792
-
-
Hung, S.Y.1
Shih, Y.P.2
Chen, M.3
Lo, S.H.4
-
41
-
-
84931097138
-
Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma
-
Patel NA, Patel PS, Vora HH. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma. Breast Dis. 2014;35(2):113-127.
-
(2014)
Breast Dis
, vol.35
, Issue.2
, pp. 113-127
-
-
Patel, N.A.1
Patel, P.S.2
Vora, H.H.3
-
42
-
-
84907276388
-
TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells
-
D'Angelo RC, Liu XW, Najy AJ, Jung YS, Won J, Chai KX, et al. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells. Mol Cancer Res. 2014;12(9):1324-33.
-
(2014)
Mol Cancer Res
, vol.12
, Issue.9
, pp. 1324-1333
-
-
D'Angelo, R.C.1
Liu, X.W.2
Najy, A.J.3
Jung, Y.S.4
Won, J.5
Chai, K.X.6
-
43
-
-
84893522248
-
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling
-
Ibrahim SA, Hassan H, Vilardo L, Kumar SK, Kumar AV, Kelsch R, et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One. 2013;8(12), e85737.
-
(2013)
PLoS One
, vol.8
, Issue.12
, pp. e85737
-
-
Ibrahim, S.A.1
Hassan, H.2
Vilardo, L.3
Kumar, S.K.4
Kumar, A.V.5
Kelsch, R.6
-
44
-
-
84895095291
-
Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation
-
Guzman JR, Koo JS, Goldsmith JR, Muhlbauer M, Narula A, Jobin C. Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629.
-
(2013)
Sci Rep
, vol.3
, pp. 1629
-
-
Guzman, J.R.1
Koo, J.S.2
Goldsmith, J.R.3
Muhlbauer, M.4
Narula, A.5
Jobin, C.6
-
45
-
-
84857640591
-
Cancer associated fibroblasts: the dark side of the coin
-
Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res. 2011;1(4):482-97.
-
(2011)
Am J Cancer Res
, vol.1
, Issue.4
, pp. 482-497
-
-
Cirri, P.1
Chiarugi, P.2
-
46
-
-
33747859659
-
Stromal fibroblasts in cancer: a novel tumor-promoting cell type
-
Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5(15):1597-601.
-
(2006)
Cell Cycle
, vol.5
, Issue.15
, pp. 1597-1601
-
-
Orimo, A.1
Weinberg, R.A.2
-
47
-
-
0033215242
-
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
-
Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999;59(19):5002-11.
-
(1999)
Cancer Res
, vol.59
, Issue.19
, pp. 5002-5011
-
-
Olumi, A.F.1
Grossfeld, G.D.2
Hayward, S.W.3
Carroll, P.R.4
Tlsty, T.D.5
Cunha, G.R.6
-
48
-
-
0036790977
-
Diversity, topographic differentiation, and positional memory in human fibroblasts
-
Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A. 2002;99(20):12877-82.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.20
, pp. 12877-12882
-
-
Chang, H.Y.1
Chi, J.T.2
Dudoit, S.3
Bondre, C.4
van de Rijn, M.5
Botstein, D.6
-
49
-
-
80055121889
-
Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers
-
Rowe RG, Keena D, Sabeh F, Willis AL, Weiss SJ. Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers. Am J Physiol Lung Cell Mol Physiol. 2011;301(5):L683-92.
-
(2011)
Am J Physiol Lung Cell Mol Physiol
, vol.301
, Issue.5
, pp. L683-L692
-
-
Rowe, R.G.1
Keena, D.2
Sabeh, F.3
Willis, A.L.4
Weiss, S.J.5
-
50
-
-
36549041840
-
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion
-
Holliday DL, Hughes S, Shaw JA, Walker RA, Jones JL. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res. 2007;9(5):R67.
-
(2007)
Breast Cancer Res
, vol.9
, Issue.5
, pp. R67
-
-
Holliday, D.L.1
Hughes, S.2
Shaw, J.A.3
Walker, R.A.4
Jones, J.L.5
-
51
-
-
58849114639
-
Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer
-
Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat. 2009;114(1):47-62.
-
(2009)
Breast Cancer Res Treat
, vol.114
, Issue.1
, pp. 47-62
-
-
Casey, T.1
Bond, J.2
Tighe, S.3
Hunter, T.4
Lintault, L.5
Patel, O.6
-
52
-
-
81855169565
-
Cancer invasion and the microenvironment: plasticity and reciprocity
-
Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 2011;147(5):992-1009.
-
(2011)
Cell
, vol.147
, Issue.5
, pp. 992-1009
-
-
Friedl, P.1
Alexander, S.2
-
53
-
-
0036512208
-
New functions for the matrix metalloproteinases in cancer progression
-
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161-74.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.3
, pp. 161-174
-
-
Egeblad, M.1
Werb, Z.2
-
54
-
-
53149100519
-
Seprase: an overview of an important matrix serine protease
-
O'Brien P, O'Connor BF. Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta. 2008;1784(9):1130-45.
-
(2008)
Biochim Biophys Acta
, vol.1784
, Issue.9
, pp. 1130-1145
-
-
O'Brien, P.1
O'Connor, B.F.2
-
55
-
-
0033567263
-
Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass
-
Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem. 1999;264(1):100-9.
-
(1999)
Eur J Biochem
, vol.264
, Issue.1
, pp. 100-109
-
-
Linebaugh, B.E.1
Sameni, M.2
Day, N.A.3
Sloane, B.F.4
Keppler, D.5
-
56
-
-
0035476863
-
Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas
-
Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res. 2001;61(19):7091-100.
-
(2001)
Cancer Res
, vol.61
, Issue.19
, pp. 7091-7100
-
-
Nielsen, B.S.1
Rank, F.2
Lopez, J.M.3
Balbin, M.4
Vizoso, F.5
Lund, L.R.6
-
57
-
-
77950931419
-
Matrix metalloproteinases: regulators of the tumor microenvironment
-
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52-67.
-
(2010)
Cell
, vol.141
, Issue.1
, pp. 52-67
-
-
Kessenbrock, K.1
Plaks, V.2
Werb, Z.3
-
58
-
-
0032533949
-
Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis
-
Peters M, Muller AM, Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood. 1998;92(10):3495-504.
-
(1998)
Blood
, vol.92
, Issue.10
, pp. 3495-3504
-
-
Peters, M.1
Muller, A.M.2
Rose-John, S.3
-
59
-
-
34249295225
-
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium
-
Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 2007;67(9):4244-53.
-
(2007)
Cancer Res
, vol.67
, Issue.9
, pp. 4244-4253
-
-
Ao, M.1
Franco, O.E.2
Park, D.3
Raman, D.4
Williams, K.5
Hayward, S.W.6
-
60
-
-
79951842547
-
Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis
-
Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson 2nd RS, et al. Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res. 2011;71(4):1272-81.
-
(2011)
Cancer Res
, vol.71
, Issue.4
, pp. 1272-1281
-
-
Franco, O.E.1
Jiang, M.2
Strand, D.W.3
Peacock, J.4
Fernandez, S.5
Jackson, R.S.6
-
61
-
-
84909607972
-
The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA Binding Protein AUF1
-
Hendrayani SF, Al-Khalaf HH, Aboussekhra A. The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA Binding Protein AUF1. J Biol Chem. 2014.
-
(2014)
J Biol Chem
-
-
Hendrayani, S.F.1
Al-Khalaf, H.H.2
Aboussekhra, A.3
-
62
-
-
18844428327
-
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
-
Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335-48.
-
(2005)
Cell
, vol.121
, Issue.3
, pp. 335-348
-
-
Orimo, A.1
Gupta, P.B.2
Sgroi, D.C.3
Arenzana-Seisdedos, F.4
Delaunay, T.5
Naeem, R.6
-
63
-
-
84886312489
-
Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype
-
Cho YA, Sung MK, Yeon JY, Ro J, Kim J. Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat. 2013;45(3):210-9.
-
(2013)
Cancer Res Treat
, vol.45
, Issue.3
, pp. 210-219
-
-
Cho, Y.A.1
Sung, M.K.2
Yeon, J.Y.3
Ro, J.4
Kim, J.5
-
64
-
-
84855463939
-
Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls
-
Narita D, Seclaman E, Ursoniu S, Ilina R, Cireap N, Anghel A. Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Rom J Morphol Embryol. 2011;52(4):1261-7.
-
(2011)
Rom J Morphol Embryol.
, vol.52
, Issue.4
, pp. 1261-1267
-
-
Narita, D.1
Seclaman, E.2
Ursoniu, S.3
Ilina, R.4
Cireap, N.5
Anghel, A.6
-
65
-
-
79952015621
-
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
-
Ravishankaran P, Karunanithi R. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J Surg Oncol. 2011;9:18.
-
(2011)
World J Surg Oncol
, vol.9
, pp. 18
-
-
Ravishankaran, P.1
Karunanithi, R.2
-
66
-
-
75849154010
-
Cancer associated fibroblasts in cancer pathogenesis
-
Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 2010;21(1):33-9.
-
(2010)
Semin Cell Dev Biol
, vol.21
, Issue.1
, pp. 33-39
-
-
Franco, O.E.1
Shaw, A.K.2
Strand, D.W.3
Hayward, S.W.4
-
67
-
-
82555181278
-
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
-
Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, Mommer C, et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol. 2011;55(7-9):861-7.
-
(2011)
Int J Dev Biol
, vol.55
, Issue.7-9
, pp. 861-867
-
-
Laoui, D.1
Movahedi, K.2
Van Overmeire, E.3
Van den Bossche, J.4
Schouppe, E.5
Mommer, C.6
-
68
-
-
84864828790
-
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
-
Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306.
-
(2012)
BMC Cancer
, vol.12
, pp. 306
-
-
Medrek, C.1
Ponten, F.2
Jirstrom, K.3
Leandersson, K.4
-
69
-
-
84868202071
-
Stromal biomarkers in breast cancer development and progression
-
Rudnick JA, Kuperwasser C. Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis. 2012;29(7):663-72.
-
(2012)
Clin Exp Metastasis
, vol.29
, Issue.7
, pp. 663-672
-
-
Rudnick, J.A.1
Kuperwasser, C.2
-
70
-
-
84889048897
-
Dendritic cells, inflammation, and breast cancer
-
Palucka K, Coussens LM, O'Shaughnessy J. Dendritic cells, inflammation, and breast cancer. Cancer J. 2013;19(6):511-6.
-
(2013)
Cancer J
, vol.19
, Issue.6
, pp. 511-516
-
-
Palucka, K.1
Coussens, L.M.2
O'Shaughnessy, J.3
-
71
-
-
80053570256
-
Innate immune cells in breast cancer--from villains to heroes?
-
Kees T, Egeblad M. Innate immune cells in breast cancer--from villains to heroes? J Mammary Gland Biol Neoplasia. 2011;16(3):189-203.
-
(2011)
J Mammary Gland Biol Neoplasia
, vol.16
, Issue.3
, pp. 189-203
-
-
Kees, T.1
Egeblad, M.2
-
72
-
-
80052206084
-
Prognostic and predictive impact of intra- and peritumoral immune infiltrates
-
Fridman WH, Galon J, Pages F, Tartour E, Sautes-Fridman C, Kroemer G. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 2011;71(17):5601-5.
-
(2011)
Cancer Res
, vol.71
, Issue.17
, pp. 5601-5605
-
-
Fridman, W.H.1
Galon, J.2
Pages, F.3
Tartour, E.4
Sautes-Fridman, C.5
Kroemer, G.6
-
73
-
-
40349094954
-
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
-
DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. 2007;9(4):212.
-
(2007)
Breast Cancer Res
, vol.9
, Issue.4
, pp. 212
-
-
DeNardo, D.G.1
Coussens, L.M.2
-
74
-
-
0036792564
-
Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues
-
Wilson KS, Roberts H, Leek R, Harris AL, Geradts J. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. Am J Pathol. 2002;161(4):1171-85.
-
(2002)
Am J Pathol
, vol.161
, Issue.4
, pp. 1171-1185
-
-
Wilson, K.S.1
Roberts, H.2
Leek, R.3
Harris, A.L.4
Geradts, J.5
-
75
-
-
84893771246
-
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
-
Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, Clouthier SG, et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene. 2015;34(6):671-80.
-
(2015)
Oncogene
, vol.34
, Issue.6
, pp. 671-680
-
-
Kim, G.1
Ouzounova, M.2
Quraishi, A.A.3
Davis, A.4
Tawakkol, N.5
Clouthier, S.G.6
-
76
-
-
36749013537
-
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells
-
Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007;9(12):1392-400.
-
(2007)
Nat Cell Biol
, vol.9
, Issue.12
, pp. 1392-1400
-
-
Gaggioli, C.1
Hooper, S.2
Hidalgo-Carcedo, C.3
Grosse, R.4
Marshall, J.F.5
Harrington, K.6
-
77
-
-
84885045558
-
Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models
-
Sung KE, Su X, Berthier E, Pehlke C, Friedl A, Beebe DJ. Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS One. 2013;8(10), e76373.
-
(2013)
PLoS One
, vol.8
, Issue.10
-
-
Sung, K.E.1
Su, X.2
Berthier, E.3
Pehlke, C.4
Friedl, A.5
Beebe, D.J.6
-
78
-
-
0035984583
-
A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line
-
To Y, Dohi M, Matsumoto K, Tanaka R, Sato A, Nakagome K, et al. A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line. Am J Respir Cell Mol Biol. 2002;27(2):220-6.
-
(2002)
Am J Respir Cell Mol Biol
, vol.27
, Issue.2
, pp. 220-226
-
-
To, Y.1
Dohi, M.2
Matsumoto, K.3
Tanaka, R.4
Sato, A.5
Nakagome, K.6
-
79
-
-
84907887777
-
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells
-
Krishnamurthy S, Warner KA, Dong Z, Imai A, Nor C, Ward BB, et al. Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells. 2014;32(11):2845-57.
-
(2014)
Stem Cells
, vol.32
, Issue.11
, pp. 2845-2857
-
-
Krishnamurthy, S.1
Warner, K.A.2
Dong, Z.3
Imai, A.4
Nor, C.5
Ward, B.B.6
-
80
-
-
84893769522
-
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling
-
Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ, Feng YM. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer. 2014;110(3):724-32.
-
(2014)
Br J Cancer
, vol.110
, Issue.3
, pp. 724-732
-
-
Yu, Y.1
Xiao, C.H.2
Tan, L.D.3
Wang, Q.S.4
Li, X.Q.5
Feng, Y.M.6
-
81
-
-
16844377774
-
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling
-
Zhang XL, Topley N, Ito T, Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem. 2005;280(13):12239-45.
-
(2005)
J Biol Chem
, vol.280
, Issue.13
, pp. 12239-12245
-
-
Zhang, X.L.1
Topley, N.2
Ito, T.3
Phillips, A.4
-
82
-
-
58149154996
-
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
-
Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112(10):3959-64.
-
(2008)
Blood
, vol.112
, Issue.10
, pp. 3959-3964
-
-
Nishimoto, N.1
Terao, K.2
Mima, T.3
Nakahara, H.4
Takagi, N.5
Kakehi, T.6
-
83
-
-
84876196796
-
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
-
Voorhees PM, Manges RF, Sonneveld P, Jagannath S, Somlo G, Krishnan A, et al. A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. Br J Haematol. 2013;161(3):357-66.
-
(2013)
Br J Haematol
, vol.161
, Issue.3
, pp. 357-366
-
-
Voorhees, P.M.1
Manges, R.F.2
Sonneveld, P.3
Jagannath, S.4
Somlo, G.5
Krishnan, A.6
-
84
-
-
77957995258
-
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
-
Rossi JF, Negrier S, James ND, Kocak I, Hawkins R, Davis H, et al. A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. Br J Cancer. 2010;103(8):1154-62.
-
(2010)
Br J Cancer
, vol.103
, Issue.8
, pp. 1154-1162
-
-
Rossi, J.F.1
Negrier, S.2
James, N.D.3
Kocak, I.4
Hawkins, R.5
Davis, H.6
-
85
-
-
79951556761
-
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
-
Hunsucker SA, Magarotto V, Kuhn DJ, Kornblau SM, Wang M, Weber DM, et al. Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma. Br J Haematol. 2011;152(5):579-92.
-
(2011)
Br J Haematol
, vol.152
, Issue.5
, pp. 579-592
-
-
Hunsucker, S.A.1
Magarotto, V.2
Kuhn, D.J.3
Kornblau, S.M.4
Wang, M.5
Weber, D.M.6
-
86
-
-
77953091816
-
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer
-
Dorff TB, Goldman B, Pinski JK, Mack PC, Lara Jr PN, Van Veldhuizen Jr PJ, et al. Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Re. 2010;16(11):3028-34.
-
(2010)
Clin Cancer Re
, vol.16
, Issue.11
, pp. 3028-3034
-
-
Dorff, T.B.1
Goldman, B.2
Pinski, J.K.3
Mack, P.C.4
Lara Jr, P.N.5
Van Veldhuizen, P.J.6
-
88
-
-
84902537885
-
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer
-
Song L, Smith MA, Doshi P, Sasser K, Fulp W, Altiok S, et al. Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer. J Thorac Oncol. 2014;9(7):974-82.
-
(2014)
J Thorac Oncol
, vol.9
, Issue.7
, pp. 974-982
-
-
Song, L.1
Smith, M.A.2
Doshi, P.3
Sasser, K.4
Fulp, W.5
Altiok, S.6
-
89
-
-
80052855899
-
Interleukin-6 as a therapeutic target in human ovarian cancer
-
Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res. 2011;17(18):6083-96.
-
(2011)
Clin Cancer Res
, vol.17
, Issue.18
, pp. 6083-6096
-
-
Coward, J.1
Kulbe, H.2
Chakravarty, P.3
Leader, D.4
Vassileva, V.5
Leinster, D.A.6
-
90
-
-
84938943738
-
The role of IL-6 in ER + breast cancer and potential use for Siltuximab, an anti-IL-6 antibody, in ER + breast cancer treatment
-
3530-3530
-
Axel A, Casneuf T, King P, Alvarez J, Hall B, Sasser K. Abstract 3530: The role of IL-6 in ER + breast cancer and potential use for Siltuximab, an anti-IL-6 antibody, in ER + breast cancer treatment. Cancer Res. 2013;73(8 Supplement):3530-0.
-
(2013)
Cancer Res
, vol.73
, Issue.8
-
-
Axel, A.1
Casneuf, T.2
King, P.3
Alvarez, J.4
Hall, B.5
Sasser, K.6
|